Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-179,275
Closed -$2.4M 1255
2025
Q3
$2.4M Sell
179,275
-941,090
-84% -$11.1M 0.01% 540
2025
Q2
$14.3M Buy
+1,120,365
New +$13.4M 0.06% 191
2024
Q4
Sell
-37,625
Closed -$482K 1156
2024
Q3
$482K Buy
+37,625
New +$461K ﹤0.01% 646
2024
Q2
Sell
-92,614
Closed -$2.1M 1112
2024
Q1
$2.1M Sell
92,614
-2,587
-3% -$60.5K 0.01% 436
2023
Q4
$2.36M Buy
+95,201
New +$1.86M 0.02% 389
2023
Q2
Sell
-145,835
Closed -$2.61M 1108
2023
Q1
$2.61M Buy
145,835
+35,190
+32% +$532K 0.02% 370
2022
Q4
$1.41M Sell
110,645
-5,721
-5% -$70.7K 0.01% 585
2022
Q3
$1.5M Sell
116,366
-8,500
-7% -$149K 0.01% 670
2022
Q2
$2.31M Buy
+124,866
New +$2.33M 0.01% 633

Other funds holding PATH

Natixis's PATH Position: Q4 2025 in Review

Natixis sold out of UiPath (PATH) in Q4 2025, closing a stake of 179,275 shares — an estimated $2.4M sold.

Natixis first reported a position in PATH in Q2 2022 and held it in 9 quarters. The position peaked at $14.3M in Q2 2025. 539 funds tracked by Wall St. Rank hold PATH as of Q4 2025.

  • Natixis reported no remaining UiPath position as of Q4 2025 after selling out during the quarter.
  • Natixis sold 179,275 UiPath shares in Q4 2025, an estimated $2.4M.
  • Natixis first reported a position in UiPath in Q2 2022 and held it in 9 quarters.
  • Natixis's UiPath position peaked at $14.3M in Q2 2025.
  • 539 funds tracked by Wall St. Rank held UiPath as of Q4 2025.

Based on Natixis's 13F filing for Q4 2025, filed 13 Feb 2026.